Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium
- PMID: 3436314
- DOI: 10.1007/BF02014241
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium
Abstract
A technique to determine the effects of combining antimycobacterial drugs in liquid medium employing the radiometric growth readings in the Bactec system was tested using 20 Mycobacterium avium complex strains. Ten of the strains had been isolated from children with lymphadenopathy and ten from adults with pulmonary disease. All isolates were resistant to streptomycin, rifampicin, isoniazid and ethambutol when tested with a conventional resistant ratio technique on Löwenstein-Jensen medium. Synergistic interactions were shown for the two-drug combinations streptomycin + ethambutol and ethambutol + rifampicin against all 20 strains. Good efficacy was also found for all three-drug combinations containing ethambutol. Thus, although most isolates of the Mycobacterium avium complex are resistant to first-line antituberculous drugs when tested individually, they are susceptible in vitro to certain combinations of these drugs. This rapid radiometric assay is an efficient means for detecting such synergy.
Similar articles
-
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.Antimicrob Agents Chemother. 1982 Jul;22(1):148-50. doi: 10.1128/AAC.22.1.148. Antimicrob Agents Chemother. 1982. PMID: 7125626 Free PMC article.
-
Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.Thorax. 1987 Nov;42(11):838-42. doi: 10.1136/thx.42.11.838. Thorax. 1987. PMID: 3424264 Free PMC article.
-
[Comparison of proportion method in Löwenstein-Jensen medium with the BACTEC 460 TB system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis isolates].Mikrobiyol Bul. 2011 Oct;45(4):623-31. Mikrobiyol Bul. 2011. PMID: 22090293 Turkish.
-
Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.J Clin Microbiol. 1998 Oct;36(10):2940-3. doi: 10.1128/JCM.36.10.2940-2943.1998. J Clin Microbiol. 1998. PMID: 9738047 Free PMC article.
-
Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.Tuberculosis (Edinb). 2007 Mar;87(2):102-8. doi: 10.1016/j.tube.2006.05.002. Epub 2006 Oct 10. Tuberculosis (Edinb). 2007. PMID: 17035089
Cited by
-
Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.Antimicrob Agents Chemother. 1988 Sep;32(9):1392-5. doi: 10.1128/AAC.32.9.1392. Antimicrob Agents Chemother. 1988. PMID: 3196000 Free PMC article.
-
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.Thorax. 2001 Mar;56(3):167-72. doi: 10.1136/thorax.56.3.167. Thorax. 2001. PMID: 11182006 Free PMC article. Clinical Trial.
-
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.BMC Pulm Med. 2019 Nov 11;19(1):212. doi: 10.1186/s12890-019-0982-8. BMC Pulm Med. 2019. PMID: 31711459 Free PMC article.
-
Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.Clin Microbiol Rev. 2001 Jul;14(3):489-512. doi: 10.1128/CMR.14.3.489-512.2001. Clin Microbiol Rev. 2001. PMID: 11432810 Free PMC article. Review.
-
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.Antimicrob Agents Chemother. 1993 Jun;37(6):1285-8. doi: 10.1128/AAC.37.6.1285. Antimicrob Agents Chemother. 1993. PMID: 8392308 Free PMC article.